Aspen guilty of collusion

UK watchdog’s provisional report implicates SA company in lifesaving drug price-hike scandal


Aspen Pharmacare has less than a month to pay the UK’s National Health Service £8m (R149m) for inflating the price of drugs sold to the service by up to 1,800%.

The SA pharmaceutical giant was, in a provisional finding, named as one of the guilty parties in a collusion scandal by the UK’s Competition and Markets Authority (CMA)...

This article is reserved for HeraldLIVE subscribers.

A subscription gives you full digital access to all our content.

Already subscribed? Simply sign in below.

Already registered on DispatchLIVE, BusinessLIVE, TimesLIVE or SowetanLIVE? Sign in with the same details.

Questions or problems? Email or call 0860 52 52 00.